Frontlight ResearchEarly access
CompletedNo phase
Diabetic Foot Self Care
Key facts
- Who runs it
- Namik Kemal University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 202 people enrolled
- Started
- 1 Apr 2023
- Ended
- 1 Oct 2024
- Type of study
- Observational
- Treatments tested
- Self-Care Tool for Diabetic Foot Prevention
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- speaking Turkish
- over 18 years old
- Not having a serious psychiatric diagnosis
- Giving written consent to participate in the study
Who cannot take part
- severe visual or auditory problems
- who did not volunteer to participate in the study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The scale, whose validity and reliability were examined in the study, consists of 26 items. The study sample consisted of 202 individuals with diabetes. Data were collected through face-to-face interviews, with approximately 30 minutes allocated to each individual. The study sample included individuals over 18 years of age, diagnosed with diabetes, who spoke, read, and wrote Turkish, and who provided verbal and written consent to participate in the study. Individuals with serious psychiatric diagnoses, cognitive problems that would impede self-expression, and those who wished to withdraw from the study at any stage were excluded from the study sample.
Treatments tested
- Self-Care Tool for Diabetic Foot Prevention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Validity and Reliability of the Turkish Version of the Self-Care Tool for Diabetic Foot Prevention
- Record updated
- 12 November 2026